# FDA Inspection 1263977 - Shandong Luxi Pharmaceutical Co., Ltd. - February 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/shandong-luxi-pharmaceutical-co-ltd/1962f256-b5c5-482f-bf56-c7bd8debf709
Source feed: FDA_Inspections

> FDA Inspection 1263977 for Shandong Luxi Pharmaceutical Co., Ltd. on February 28, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263977
- Company Name: Shandong Luxi Pharmaceutical Co., Ltd.
- Inspection Date: 2025-02-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1263977 - 2025-02-28](https://www.keypedia.com/records/fda_inspections/shandong-luxi-pharmaceutical-co-ltd/adf84eef-920e-47e9-b417-621cbd3de422)
- [FDA Inspection 1099165 - 2019-07-24](https://www.keypedia.com/records/fda_inspections/shandong-luxi-pharmaceutical-co-ltd/de895a47-d953-4bb9-a782-5dbe88d30880)

Company: https://www.keypedia.com/companies/shandong-luxi-pharmaceutical-co-ltd/d676adc9-409f-4ea4-881b-d2cf1ab1e684

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c